three other compounds have been approved in Japan (Ipragliflozin, Tofogliflozin, Luseogliflozin), while others are in development (Ertugliflozin and Sotagliflozin) ( Canagliflozin Canagliflozin [(1 S )-1,5-andro-1-[3-[[5-(4-fluorophenyl)-2-tienil]metil]-4-metilfenil]-d- GLUCITOLO emirate], is a C-glycosyl compound that is used (in the hemihydrate form) for the treatment of T2DM through inhibition of sodium/glucose co-transporter 2 ( It was initially approved by the FDA in 2013 for the management of T2DM and later approved in 2018 for a second indication of reducing the risk of cardiovascular events in patients diagnosed with T2DM
During the keto transition weeks, temporarily increasing sodium intake to 4,000 to 5,000mg per day can meaningfully reduce keto adaptation symptoms
They can identify relevant cautions and precautions that may not be apparent to a layperson
The Strategy: Incorporate fermented foods like kimchi, kefir, or sauerkraut alongside your fiber
UK SmPCs note that GLP-1 receptor agonists have been associated with thyroid C-cell tumours in rodent studies, though a causal relationship in humans has not been established